Citi Annual Global Healthcare Conference 2025 December 2, 2025 10:30 AM ESTCompany ParticipantsIlya Yuffa - Executive VP ...

Indiana shows high potential for the state to become the premiere destination to research, commercialize, scale biotechnology ...

The UK is set to sign a zero-tariff pharmaceuticals deal with the US, lowering rebates, raising QALY thresholds and ...

Dec 1 () - The World Health Organization on Monday issued its first guideline on the use of GLP-1 therapies for obesity,​ ...

In a landmark achievement for the healthcare sector, Eli Lilly and Company has cemented its status as an industry titan by reaching a historic $1 trillion market valuation. This milestone makes it the ...

U.S. stocks are opening with small gains on the final trading day of November. The S&P rose 0.2% and needs a slightly larger ...

Eli Lilly and Company, the world’s No. 1 drugmaker by market capitalization in the United States, will establish a production base in Korea for its glucagon-like peptide-1 (GLP-1) obesity treatment ...

The endowment of Eli Lilly & Co. (LLY), which focuses on charitable causes, has now become the largest in the U.S. with more ...

Issue 2: Life Support - How Ireland’s FDI base is preparing for the next wave in connected health Advanced optics, lighting, ...

Eli Lilly and Company is rated Sell due to extreme dependence on GLP-1 drugs & valuation that assumes near-perfect conditions ...

Several multinational companies (MNCs) have exited Pakistan since 2022 due to a host of economic challenges, each departure ...

A pill version of A/S’s Ozempic failed to slow the progression of Alzheimer’s disease in a pair of long-shot studies that ...